Described herein are pharmaceutical packaging systems which stop oxidative degradation of morphine, hydromorphone, promethazine as well as other oxygen-sensitive medication, such systems which include a syringe using an oxygen permeable suggestion cap, a hermetically sealed oxygen barrier blister packaging with extremely minimal permeability to oxy